Delivery Order SPE2DB22D2211-SPE2DB25FRPUD

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,202.44, is for the delivery of 4564840964 - Levocetirizine 5 mg Tablets in 90-count packages. The award is a firm fixed-price delivery order with a completion date of June 10, 2024. Amerisourcebergen is a major pharmaceutical distribution company that has been awarded several federal contracts to supply a wide range of medications...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Cetirizine HCL 1 mg/ml solution in 120 ml bottles. The contract has a ceiling value of $6,330.85 and a period of performance through March 12, 2024. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded solely to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,249.04, is for the delivery of CETIRIZINE-PSE ER 5-120 MG TAB 12S medication. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of January 30, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cetirizine HCL 1 MG/ML solution, a pharmaceutical product, with a ceiling value of $23,492.91 and a performance period ending on January 15, 2025. The contract is a Firm Fixed Price (FFP) delivery order, which is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Cetirizine HCL 1 mg/ml solution (120 ml) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,812.91 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025. This IDC with the DLA Troop Support Medical enables the agency to efficiently procure a wide range of essential...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,202.06 firm fixed-price delivery order is for the supply of CETIRIZINE-PSE ER 5-120 MG TAB 24S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,420,169 units of Cetirizine HCL 5 mg tablets, a generic antihistamine medication. The total ceiling value of the contract is $5,738.30, with a firm fixed price. The contract is a delivery order that runs from November 13, 2024, to November 14, 2024, and is not designated as a set-aside. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $3,384.24 firm fixed price contract is for the delivery of Cetirizine Hydrochloride 1 mg/mL solution, a prescription allergy medication. The order has an ultimate completion date of May 13, 2024. This award is issued under AmerisourceBergen's Indefinite Delivery...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,841,479 cetirizine hydrochloride 5 mg tablets in 100-count packages. The $2,731.81 contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order contract is part of a larger...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation and a leading global pharmaceutical sourcing and distribution services company. The contract has a ceiling value of $1,031.04 and is for the delivery of 4564151985 units of Cetirizine 10mg 500 count tablets. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRPUD
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,488.84, is for the supply of 4567062416 - Levocetirizine 2.5 mg/5 ml solution, 148 ml, with a period of performance through January 28, 2025. This contract represents a small portion of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/28/25, 9:52 AM